SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : lcav -- Ignore unavailable to you. Want to Upgrade?


To: Manny Gugliuzza who wrote (253)4/1/1998 4:23:00 PM
From: Harry W. Lowe  Read Replies (1) | Respond to of 942
 
AR,

Thanks to Amy Feller and her post #483 on the VISX thread, I obtained the following article from USA Today. This article compares Lasik to PRK, and more importantly describes the need for corrective eye procedures to correct eye problems.

Also, the current activity in LCAV appears very constructive in that regardless of declining momentum and short term sell signals, the stock manages to hold above $1.625/share, very good holding action.

Harry

----------------------------------------------------------------------

USA Today Article

Laser surgery appeals for appearance for Stephanie Chalupka, the decision to pay $5,000 to have her eyeballs sliced, first by a knife and then by a laser, came after a day of terror on Typhoon Mountain.

A storm caused an emergency evacuation at the Disney World water park, forcing the ill-sighted mom to rush her two kids to safety without her glasses, which were in a locker.

It was chaos in a blur. "People were rushing around and screaming. I couldn't read the signs to tell us where to go," says Chalupka, a nursing professor at Worcester (Mass.) State College. "I was frightened out of my mind." With that, Chalupka, 42, decided to became one of thousands of Americans who took a chance on laser eye surgery in which the eye is cut to change its shape and improve its focus. It's scary and expensive to some and still comes with risks attached, but "not being able to protect my children was really frightening," she says. Chalupka now has perfect vision.

As word spreads of people throwing away their glasses, others are
lining up for the services of laser surgeons. In 1996, surgeons
performed laser eye surgery to correct vision 100,000 times. That
number doubled last year and another 350,000 surgeries are expected
this year.

If last week's Federal Trade Commission price fixing action against
laser manufacturers holds, the cost may begin to come down for the
first time. But experts warn the risk of permanent damage should be weighed and that people should pick only the most experienced surgeons.

"Don't be the guinea pig," warns Irving Arons of Spectrum Consulting,
who has studied the trends in laser eye surgery for 15 years. While more than 200,000 people in the USA have had laser eye surgery, millions more could benefit. More than 63 million people in the
USA are nearsighted, the condition laser surgery helps the most. The
technique has also been used to help those with other vision problems,
including astigmatism - distortion from a misshapen eye - and
farsightedness.

The business potential has put a new glimmer in the eyes of doctors.
"It's transformed ophthalmology from the world of medicine to the
world of business, "says Arun Lakra, an ophthalmologist and co-author
of the book, In Search of 20/20: Everything you need to know about laser eye surgery. "From a dollars standpoint, it's injecting new
blood and money into a field that had been a little dormant."

Michael Lachman, an analyst for the investment banking firm
Hambrecht & Quist, says laser eye surgery will be a $1 billion industry by 2000. "You have all these people saying it's the best $4,000 or $5,000 they've ever spent", he says. "It's hard to find people that aren't ecstatic about it."

The idea for this kind of surgery dates to the late 1800s. That's when a European ophthalmologist envisioned improving an eye's focus by
cutting the eyeball with a knife to change its shape. Japanese doctors
developed a technique that worked in the 1940s. It was first performed
in the USA in 1978. But computers and lasers made the task much more successful in the 1990s. And this area of surgery is evolving quickly. A new version is gaining momentum before governmental approval.

The basic laser surgery, which is approved by the Food and Drug
Administration, is photorefractive keratectomy or PRK. It involves the
surgeon removing micro-thin layers of the cornea with a laser.

When the layers are removed from the cornea - the very front of the
eye which protects the lens through which we see - light is focused on
the retina, making vision clear.

To shave the layers from the cornea, surgeons use one of two excimer
lasers approved by the FDA to deliver bursts of ultraviolet light. The
laser can vaporize precisely targeted corneal tissue with better precision than a surgeon using a knife. The procedure takes about 15 minutes and the eye heals with the aid of medicated drops within a few months. But surgeons have developed a new procedure that is based on PRK but which backers say has advantages.

In laser in situ keratomileusis, or LASIK, a surgeon cuts a flap of the cornea on the front of the eye with a knife-like instrument, peels the flap to one side and performs the PRK with the laser. The flap is then replaced as natural bandage. Benefits include less pain, clearer vision faster after surgery and fewer infections.

The big risk: a flub while cutting the flap is devastating. "You're actually cutting into the eye with a blade instead of zapping the
superficial surface,"Lakra says. ''It's a more surgeon-dependent
procedure. It raises the question of how you select your surgeon."

LASIK has not yet been approved by the FDA, but it has gained favor
among skilled surgeons and their patients. Analysts say LASIK may be
approved this year.

The FDA regulates drugs and medical devices but does not control
how doctors practice medicine. So a doctor can perform the procedure
before it has been fully studied in clinical trials as long as the patient is told of the known risks. FDA approval would mean doctors could advertise the procedure. But word of the surgery has spread quickly without advertising. On the scene just three years, LASIK will account for more than 65% of laser eye surgeries in the USA this year and more than 70% of those worldwide, according to Arons' own survey of surgeons.

Most experienced laser eye surgeons are switching to LASIK. Nearly
70% of the procedures performed by the busiest laser eye surgeons last
year were LASIK cases, compared to 47% the year before, the survey
found.

LASIK is also more expensive, about $2,500 per eye compared to $1,500 for PRK. Because both procedures are considered cosmetic, neither is covered by insurance. "With all of the things that are not covered by insurance, I don't think this should be covered," says Chalupka. "It's cosmetic. I like the way I look without glasses." Not everyone is so pleased with the results. Steve Samuels, a 34-year-old psychology professor at the Air Force Academy in Colorado Springs, Colo., warns others not to rush into the decision. He's been struggling with poor night vision and halos around bright lights - typical side effects that usually clear up within a few months - ever since he had his eyes done in early March. "I woke up the next morning and I couldn't read," he says. "Nobody told me that was going to happen."

There are no public figures from the government on LASIK yet, but
doctors say its side effects seem less problematic than those for PRK.
The PRK studies found:

 5% of patients still needed glasses for distance; 15% for situations like driving.

 Many patients saw haze, glare or halos around lights for up to six
months after surgery. As the eye tissue that's been cut heals, these effects almost always disappear.

 5% of patients had slightly worse vision after surgery.

 As people age, they may still need reading glasses.

 Long-term risks are unknown. Nobody knows if there are problems
that might arise 10 to 20 years after surgery. Samuels says he had trouble getting facts before his surgery.

"I wish I had pushed them more," he says. "I would have liked to see
more numbers." "You can get caught up in the sales, "Sameuls says. "I'd say don't rush your doctor. It's surgery. There's a knife, there's a laser and they're your eyes."

The industry agrees, urging patients to ponder the risks carefully before reaching a decision. Both the FDA and the Federal Trade Commission have monitored advertising for unsubstantiated claims that might mislead consumers.

The FDA says some patients have been permanently injured, including
cases of blindness that required corneal transplants. Last week, the FTC voted to charge the two companies that sell the government-approved lasers with price-fixing. If successful, that action could cut the price of seeing more clearly by $100 to $250 per eye.

The FTC estimates consumers were overcharged about $30 million last
year because of the arrangement between VISX of Santa Clara, Calif.,
and Summit Technology of Waltham, Mass. At the same time, other doctors are offering even newer procedures that also change the shape of eyes.

In one, a ring inserted into the eye would change the shape of the eye
much the way the laser surgery does, casting the light onto the retina to generate a crisp image. In the other, an internal lens would correct the vision the way a contact lens does when placed atop the eye, but the internal lens would be permanent.

"Joe consumer out there is a confused puppy right now," Lakra says.
"They've heard stories, but they're reluctant to have anything done."
He encourages patients to look for the most qualified doctor and not
expect a miracle.

Ernest Kornmehl, medical director at the center for laser vision
correction in Boston who operated on Chalupka, agrees. "The best patient is the educated patient," he says. "We only do the
procedure on people with very realistic expectations. Patients who look at it as throwing away their glasses will be disappointed."

By Robert Davis, USA TODAY

Cover story index

---------------------------------------------------------------------